Monday, May 03, 2021 1:54:12 PM
AV1177, your statement is not true, you are deliberately deceiving people!!! Why???
“ The DCVax trial randomized 331 out of 962 GBM patients they considered.
The majority of those excluded were for the reason of disease progression."
You are right. I made an error. But it only amplifies my point.
I should have said The DCVax trial randomized 331 out of 1296 GBM patients they considered.
I subtracted 306 from 1268. I should have subtracted 306 from 1599 to come up with the number of GBM patients considered for this trial.
Below is from Liau's "Blended paper":
Recent NWBO News
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
